Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37282346.
- Also identified by DOI 10.1093/cid/ciad348 and PMC identifier 10552581.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.
Medical subject headings
- COVID-19
- Glucosephosphate Dehydrogenase
- Glucosephosphate Dehydrogenase Deficiency